Hearing News Watch

Featured image for “Oticon to Conclude Supply Arrangement with OneSource Hearing Amid Industry-wide Distribution Shifts”
Aug. 14, 2025

Oticon to Conclude Supply Arrangement with OneSource Hearing Amid Industry-wide Distribution Shifts

HHTM
SOMERSET, NEW JERSEY — Oticon, Inc. announced today that it will end its supply arrangement with OneSource Hearing LLC, effective September 15, 2025. The company expects no disruption to existing customer services. This change is part of Oticon’s strategy to provide products either directly or through select strategic partners. Hearing care professionals affected by the shift will still have access
Featured image for “Voting Now Open: 2025 Hearing Technology Innovator Awards”
Aug. 13, 2025

Voting Now Open: 2025 Hearing Technology Innovator Awards

HHTM
Hearing Health & Technology Matters (HHTM), an online resource for hearing professionals and consumers with hearing loss, has today announced the opening of the public voting period for the 6th annual Hearing Technology Innovator Awards™. The international awards program honors technological innovation and achievement across the hearing industry, while also supporting nonprofit organizations dedicated to advancing hearing health. Since launching
Featured image for “New Study Examines Stigma Around Hearing Loss and Hearing Aids”
Aug. 12, 2025

New Study Examines Stigma Around Hearing Loss and Hearing Aids

HHTM
One in three adults over the age of 50 are keeping their hearing loss a secret, often because they fear being judged. An international research program has found that hearing loss is still linked to stereotypes about aging and disability, which can discourage people from seeking help. The findings, published in a special issue of the International Journal of Audiology,
Featured image for “Vestibular Function Testing Aids in Differentiating Menière’s Disease from Vestibular Migraine, Study Finds”
Aug. 07, 2025

Vestibular Function Testing Aids in Differentiating Menière’s Disease from Vestibular Migraine, Study Finds

HHTM
A new study from the Netherlands provides evidence that vestibular function tests, particularly the video head impulse test (vHIT) and caloric testing, can support clinicians in distinguishing between Menière’s disease (MD) and vestibular migraine (VM)—two vestibular conditions that frequently present with overlapping symptoms. The research, conducted at the Apeldoorn Dizziness Centre and published in Frontiers in Neurology, analyzed 668 patients
Featured image for “Hearing Health Workforce Grows, But Shortages Persist in Rural U.S.”
Aug. 01, 2025

Hearing Health Workforce Grows, But Shortages Persist in Rural U.S.

HHTM
A new study published in JAMA Otolaryngology–Head & Neck Surgery reveals that despite significant growth in the number of U.S. hearing health care (HHC) professionals over the past decade, the majority of the country continues to experience access shortages—particularly in rural areas. Between 2012 and 2022, the number of hearing health professionals, including audiologists and hearing instrument specialists, increased by
Featured image for “Study Looks at Real-World Sound Exposure in People with and without Tinnitus”
Aug. 01, 2025

Study Looks at Real-World Sound Exposure in People with and without Tinnitus

HHTM
A new study using personal noise dosimetry has found that people with tinnitus experience significantly quieter daily environments than those without the condition. Published in Scientific Reports, the research offers novel insights into how individuals with tinnitus navigate their soundscapes—and raises important questions about the role of lifestyle and sound tolerance in managing the condition. The researchers equipped 108 adults,
Featured image for “EUHA 2025 Announces Topic-Focused Lecture Program and Keynote Speaker”
Jul. 31, 2025

EUHA 2025 Announces Topic-Focused Lecture Program and Keynote Speaker

HHTM
The scientific lecture program for the 69th International Congress of Hearing Aid Acousticians (EUHA) will feature more than 25 presentations and five tutorials. For the first time, the program has been organized into thematic clusters to help attendees tailor their experience based on specific areas of interest. The congress will open with a keynote address by Dr. Markus Peifer, Head
Featured image for “H1 2025: Amplifon Delivers Revenue Growth, Targets Margin Gains with ‘Fit4Growth’ Initiative”
Jul. 29, 2025

H1 2025: Amplifon Delivers Revenue Growth, Targets Margin Gains with ‘Fit4Growth’ Initiative

HHTM
MILAN, ITALY — Global hearing care provider Amplifon has reported its first-half 2025 financial results, showing modest revenue growth despite facing economic uncertainty, foreign exchange pressures, and softening consumer demand in key markets. While revenue rose slightly, the company saw declines in profitability and announced a strategic plan to improve operational efficiency and long-term competitiveness. First-Half Results Reflect Market Pressures
Featured image for “Sonova Adjusts U.S. Distribution Strategy, Announces End to Supply Relationship with CQ Partners in September”
Jul. 28, 2025

Sonova Adjusts U.S. Distribution Strategy, Announces End to Supply Relationship with CQ Partners in September

HHTM
AURORA, ILLINOIS – Sonova USA Inc. announced today that it will discontinue its supply relationship with CQ Partners, LLC, effective September 13, 2025. The decision is part of Sonova’s ongoing strategy to streamline operations and focus on direct engagement with hearing care professionals. No disruption to existing customer services is anticipated. CQ Partners, formed in 2021 through the merger of
Featured image for “Meclizine Use Linked to Higher Fall Risk in Adults With Dizziness, Study Finds”
Jul. 24, 2025

Meclizine Use Linked to Higher Fall Risk in Adults With Dizziness, Study Finds

HHTM
A large-scale study published this week in JAMA Otolaryngology–Head & Neck Surgery has found that meclizine, a commonly prescribed medication for dizziness and vertigo, is associated with a significantly increased risk of injurious falls in both older and younger adults. The findings raise concerns about the routine use of this vestibular suppressant across care settings and age groups. Meclizine, a